Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) shares rose 36.8% during trading on Friday . The stock traded as high as C$0.13 and last traded at C$0.13. Approximately 929,313 shares changed hands during mid-day trading, an increase of 383% from the average daily volume of 192,453 shares. The stock had previously closed at C$0.10.
Voyageur Pharmaceuticals Stock Performance
The company has a market cap of C$17.43 million, a price-to-earnings ratio of -12.50 and a beta of 0.32. The company has a current ratio of 0.17, a quick ratio of 0.84 and a debt-to-equity ratio of 3.21. The stock’s 50 day moving average price is C$0.07 and its 200 day moving average price is C$0.06.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Featured Stories
- Five stocks we like better than Voyageur Pharmaceuticals
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- Stock Market Upgrades: What Are They?
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
